Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices
A Chieffo, D Dudek, C Hassager… - … Heart Journal Acute …, 2021 - academic.oup.com
There has been a significant increase in the use of short-term percutaneous ventricular
assist devices (pVADs) as acute circulatory support in cardiogenic shock and to provide …
assist devices (pVADs) as acute circulatory support in cardiogenic shock and to provide …
Lactate clearance is associated with improved survival in cardiogenic shock: a systematic review and meta-analysis of prognostic factor studies
JA Marbach, S Stone, B Schwartz, M Pahuja… - Journal of cardiac …, 2021 - Elsevier
Objective Elevated blood lactate levels are strongly associated with mortality in patients with
cardiogenic shock. Recent evidence suggests that the degree and rate at which blood …
cardiogenic shock. Recent evidence suggests that the degree and rate at which blood …
Pulmonary artery catheter use and risk of in-hospital death in heart failure cardiogenic shock
Abstract Background Pulmonary artery catheters (PACs) are increasingly used to guide
management decisions in cardiogenic shock (CS). The goal of this study was to determine if …
management decisions in cardiogenic shock (CS). The goal of this study was to determine if …
Clinical course of patients in cardiogenic shock stratified by phenotype
Background Cardiogenic shock (CS) patients remain at 30% to 60% in-hospital mortality
despite therapeutic innovations. Heterogeneity of CS has complicated clinical trial design …
despite therapeutic innovations. Heterogeneity of CS has complicated clinical trial design …
[HTML][HTML] Nrf2 activation: a key mechanism in stem cell exosomes-mediated therapies
Exosomes are nano-sized membrane extracellular vesicles which can be released from
various types of cells. Exosomes originating from inflammatory or injured cells can have …
various types of cells. Exosomes originating from inflammatory or injured cells can have …
[HTML][HTML] Integrated bioinformatics-based analysis of hub genes and the mechanism of immune infiltration associated with acute myocardial infarction
Y Wu, T Jiang, J Hua, Z Xiong, H Chen, L Li… - Frontiers in …, 2022 - frontiersin.org
Background Acute myocardial infarction (AMI) is a fatal disease that causes high morbidity
and mortality. It has been reported that AMI is associated with immune cell infiltration. Now …
and mortality. It has been reported that AMI is associated with immune cell infiltration. Now …
Lactate clearance as a surrogate for mortality in cardiogenic shock: insights from the DOREMI trial
JA Marbach, P Di Santo, NK Kapur… - Journal of the …, 2022 - Am Heart Assoc
Background Recent studies have shown improved outcomes in cardiogenic shock through
protocols directed toward early identification and initiation of mechanical circulatory support …
protocols directed toward early identification and initiation of mechanical circulatory support …
[Retracted] Activation of PTEN/P13K/AKT Signaling Pathway by miRNA‐124‐3p‐Loaded Nanoparticles to Regulate Oxidative Stress Attenuates Cardiomyocyte …
Y Cheng, Q He, N Li, M Luo - Oxidative Medicine and Cellular …, 2022 - Wiley Online Library
As a common cardiovascular disease, acute myocardial infarction seriously affects the
health and life of patients. miRNAs play an important role in acute myocardial infarction …
health and life of patients. miRNAs play an important role in acute myocardial infarction …
[HTML][HTML] Cardiac troponin I but not N-terminal pro-B-type natriuretic peptide predicts outcomes in cardiogenic shock
T Schupp, J Rusnak, J Forner, K Weidner… - Journal of Personalized …, 2023 - mdpi.com
This study investigates the prognostic value of cardiac troponin I (cTNI) and N-terminal pro-B-
type natriuretic peptide (NT-proBNP) levels in patients with cardiogenic shock (CS). Data …
type natriuretic peptide (NT-proBNP) levels in patients with cardiogenic shock (CS). Data …
[HTML][HTML] Comprehensive bioinformatics analytics and in vivo validation reveal SLC31A1 as an emerging diagnostic biomarker for acute myocardial infarction
S Zhou, L Wang, X Huang, T Wang, Y Tang… - Aging (Albany …, 2024 - ncbi.nlm.nih.gov
Background: Globally, Acute Myocardial Infarction (AMI) is a common cause of heart failure
(HF), which has been a leading cause of mortality resulting from non-communicable …
(HF), which has been a leading cause of mortality resulting from non-communicable …